pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 16·1 min read
save

Congress urged to swiftly reauthorize Pandemic and All-Hazards Preparedness Act

Jun 16, 2026·read at STAT ↗RegulatoryNeutral

Former assistant secretary for preparedness Craig Vanderwagen and former Senate staffer Jennifer Alton argue that the Pandemic and All-Hazards Preparedness Act needs prompt reauthorization. They note that the Trump administration preserved the Administration for Strategic Preparedness and Response (ASPR) and nominated a new assistant secretary to lead the agency.

ASPR, housed within HHS, coordinates the nation’s medical and public health response to biological threats, natural disasters, and other health emergencies, yet it remains largely unknown to the public.

The authors call on Congress to confirm the administration’s nominee quickly and to renew the PAHPA law, arguing that doing so will sustain the momentum in strengthening national health security before the next emergency arrives.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Opinion: Congress must reauthorize the Pandemic and All-Hazards Preparedness Act”

read at STAT ↗
993 words · retrieved Jun 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE
topics
Vaccine

related stories

  • 4d agoGSK laying off 1.2K+ in BelgiumBioSpace
  • Sep 11mRNA cancer vaccines’ biggest barriers to marketBioPharma Dive
  • Sep 8Moderna and Merck’s mRNA success fuels focus on ‘scaling out and scaling down’BioSpace
  • Aug 28BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 testFierce Biotech
  • Aug 21Scientists deploy Merck’s Ebola vaccine in DRCSTAT